TotalMarketCap

Heron Therapeutics

HRTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$52.836 M

$0.28 -6.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Heron Therapeutics (HRTX) has a market capitalization of $52.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$20.0M

Loss-making

Shares outstanding

189,852,307

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #331Rein TherapeuticsRNTX$53.6M
  2. #332Verrica PharmaceuticalsVRCA$53.4M
  3. #333Heron TherapeuticsHRTX$52.8M
  4. #334TalpheraTLPH$52.7M
  5. #335Pliant TherapeuticsPLRX$50.5M

What if Heron Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$148,730.74

Per share 534,426× higher

Bitcoin $1.53T

$8,047.56

Per share 28,917× higher

Apple $5.02T

$26,419.39

Per share 94,931× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Heron Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.